B · Normal
[Maiwei Bio: Plans to increase capital to Lianwei Chuangyuan by RMB 825 million and transfer TCE project assets] On September 28, Maiwei Biotechnology (688062.SH) announced that the company plans to increase capital from its wholly-owned subsidiary Lianwei Chuangyuan by RMB 825 million and transfer TCE project-related assets to it for RMB 826 million. At the same time, Lianwei Chuangyuan plans to introduce five investors to increase its capital by a total of 160 million yuan. After the transaction is completed, the company is expected to hold 71.21% of the equity of Lianwei Chuangyuan and remain its controlling shareholder.
A-share announcement express 🕐 2026-09-28 18:59
#A-share announcement express
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Qingyi Optoelectronics: 55nm PSM products have entered the customer online cert 09-28 21:56 [Changxin Technology: Plans to invest 24.1 billion yuan and 10.8 billion yuan re 09-28 21:29 [Haimuxing: Plans to raise no more than 2.263 billion yuan in additional capital 09-28 21:09 [*ST Huaxing: Signed a Reorganization Investment Agreement with Industrial Inves 09-28 21:08 [GAC Group: Plans to purchase 50% equity of FAW Toyota Motor Co., Ltd. through t 09-28 20:53 [Yuexin Semiconductor: There are 358,848 winning numbers] On September 28, Yuexi 09-28 20:34

Comments

0/500
Captcha (click to refresh)
No comments yet